|
|
|
| Serum Levels Of Lbp and Scd14 in Patients with Primary Sclerosing Cholangitis and Their Relationship with Prognosis |
| LI Zhi-han, ZHANG Xi-liang |
| Department of Gastroenterology, Shangqiu First People's Hospital, Shangqiu Henan 476100, China |
|
|
|
|
Abstract 【Objective】 To investigate the serum levels of lipopolysaccharide binding protein (LBP) and soluble CD14 (sCD14) in patients with primary sclerosing cholangitis (PSC) and their relationship with prognosis. 【Methods】 87 patients with PSC from January 2008 to January 2014 were selected as the study subjects. The serum levels of LBP and sCD14 were measured by ELISA, and the relationship between them and the prognosis of patients with PSC was analyzed. 【Results】 The incidence of poor prognosis was 40.23% (35/87) in 87 patients with PSC, including 11 cases of liver failure (12.64%), 8 cases of hepatobiliary carcinoma (9.20%), 12 cases of secondary biliary cirrhosis (13.79%) and 4 cases of death (4.60%). The serum levels of LBP and sCD14 in patients with poor prognosis were higher than those in patients with good prognosis (P<0.05). Logistic multivariate regression analysis showed that ALB, TBIL, IL-8, LBP and sCD14 were closely related to the prognosis of PSC patients (P<0.05). The A UC of model C in evaluating the prognosis of PSC patients was higher than that of model A and model B (P<0.05). 【Conclusion】 Serum LBP and sCD14 are correlated with the prognosis of patients with PSC. Detection of serum LBP and sCD14 is helpful to evaluate the prognosis of patients with PSC.
|
|
Received: 28 August 2019
|
|
|
|
|
|
[1] KUMMEN M, HOLM K, ANMARKRUD JA, et al. The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls[J].Gut,2017,66(4):611-619.
[2] HAMOIS D M, YATACO M L, NAKHLEH R E. Recurrence of autoimmune hepatitis, primary biliary cirrhosis, and primary sclerosing cholangitis after transplantation[J].Clin Liver Dis (Hoboken),2014,3(4):90-92.
[3] HOV J R, KARLSEN T H. The microbiome in primary sclerosing cholangitis: current evidence and potential concepts[J].Semin Liver Dis,2017,37(4):314-331.
[4] LAZOU AHREN I, BJARTELL A, EGESTEN A, et al. Lipopolysaccharide-binding protein increases toll-like receptor 4-dependent activation by nontypeable Haemophilus influenzae[J].J Infect Dis,2001,184(7):926-930.
[5] TISCHENDORF J J, GEIER A, TRAUTWEIN C. Current diagnosis and management of primary sclerosing cholangitis[J].Liver Transpl,2008,14(6):735-746.
[6] RUDOLPH G, GOTTHARDT D, KLÖTERS-PLACHKY P, et al. Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis[J].J Hepatol,2009,51(1):149-155.
[7] COTTER J M, BROWNE LP, CAPOCELLII K E, et al. Lack of correlation of liver tests with fibrosis stage at diagnosis in pediatric primary sclerosing cholangitis[J].J Pediatr Gastroenterol Nutr,2018,66(2):227-233.
[8] AGISOTELLI D, ALEXOPOULOU A, VASILIEVA L, et al. Response to lipopolysaccharide binding protein predicts decompensated cirrhosis mortality? It is too early[J].Liver Int,2017,37(7):1085-1086.
[9] LECOMTE M, COUËDELO L, MEUGNIER E, et al. Soybean polar lipids differently impact adipose tissue inflammation and the endotoxin transporters LBP and sCD14 in flaxseed vs. palm oil-rich diets[J].J Nutr Biochem,2017,43:116-124.
[10] TISCHENDORF J J, HECKER H, Krüger M, et al. Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: A single center study[J].Am J Gastroenterol,2007,102(1):107-114.
[11] KITCHENS R L, THOMPSON P A . Modulatory effects of sCD14 and LBP on LPS-host cell interactions[J].J Endotoxin Res,2005,11(4):225-229.
[12] 黄春洋, 陈杰, 刘燕敏, 等. 肠道菌群在自身免疫性肝病发生发展及治疗中的作用[J].临床肝胆病杂志,2019,35(1):206-208. |
|
|
|
2021, Vol. 38 
